-+ 0.00%
-+ 0.00%
-+ 0.00%

Rothschild & Co Upgrades Abbott Laboratories to Buy, Raises Price Target to $127

Benzinga·10/02/2026 09:55:23
语音播报
Rothschild & Co analyst Ed Ridley-Day upgrades Abbott Laboratories (NYSE:ABT) from Neutral to Buy and raises the price target from $119 to $127.